PA 2120 (Valproic Acid 250 mg)
Pill with imprint PA 2120 is White, Capsule-shape and has been identified as Valproic Acid 250 mg. It is supplied by Teva Pharmaceuticals USA.
Valproic acid is used in the treatment of epilepsy; schizoaffective disorder; seizure prevention; mania; migraine prevention and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Valproic acid 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for PA 2120
Valproic Acid
- Imprint
- PA 2120
- Strength
- 250 mg
- Color
- White
- Size
- 19.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Fatty acid derivative anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk - When treating epilepsy, X - Not for use in pregnancy - When treating migraine
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA
- National Drug Code (NDC)
- 50111-0852
- Inactive Ingredients
-
corn oil, FD&C Blue No. 1, gelatin, glycerin, water, titanium dioxide
Note: Inactive ingredients may vary.
More about valproic acid
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 40 Reviews
- Drug class: fatty acid derivative anticonvulsants
- FDA Alerts (5)
Consumer resources
- Valproic acid
- Valproic Acid Capsules
- Valproate Injection
- Valproic Acid Liquid
- Valproic acid (Advanced Reading)
Other brands: Valproate Sodium, Depakene, Depacon, Stavzor
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
